Ma Xin,Zhou Kai,Liang Yinbo,et al.Meta-analysis of risk factors associated with recurrence of thyroid carcinoma in children and adolescents[J].Journal of Clinical Pediatric Surgery,,22():671-679.[doi:10.3760/cma.j.cn101785-202211043-013]
Click Copy

Meta-analysis of risk factors associated with recurrence of thyroid carcinoma in children and adolescents

References:

[1] Zheng RS, Zhang SW, Zeng HM, et al.Cancer incidence and mortality in China, 2016[J].J Natl Cancer Cent, 2022, 2(1):1-9.DOI:10.1016/j.jncc.2022.02.002.
[2] Silverman DA, Wanner R, Walz P, et al.Pediatric head and neck malignancies[M].London:Intech Open, 2021.DOI:10.5772/intechopen.98316.
[3] Ni X, Li Z, Li XP, et al.Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China:a cross-sectional study[J].Lancet, 2022, 400(10357):1020-1032.DOI:10.1016/S0140-6736(22)01541-0.
[4] 张桂萍, 詹维伟.儿童及青少年甲状腺癌超声诊断[J].中国实用外科杂志, 2022, 42(6):643-648.DOI:10.19538/j.cjps.issn1005-2208.2022.06.10. Zhang GP, Zhan WW.Ultrasonic diagnosis of thyroid cancer in children and adolescents[J].Chin J Pract Surg, 2022, 42(6):643-648.DOI:10.19538/j.cjps.issn1005-2208.2022.06.10.
[5] 田文, 万政.重视儿童及青少年甲状腺癌的规范化诊治[J].中国实用外科杂志, 2022, 42(6):621-624, 666.DOI:10.19538/j.cjps.issn1005-2208.2022.06.05. Tian W, Wan Z.Paying greater attention to standardized diagnosis and treatment of thyroid cancer in children and adolescents[J].Chin J Pract Surg, 2022, 42(6):621-624, 666.DOI:10.19538/j.cjps.issn1005-2208.2022.06.05.
[6] de Jong MC, Gaze MN, Szychot E, et al.Treating papillary and follicular thyroid cancer in children and young people:single UK-center experience between 2003 and 2018[J].J Pediatr Surg, 2021, 56(3):534-539.DOI:10.1016/j.jpedsurg.2020.07.034.
[7] 杨崚怡, 郭凯, 钱凯, 等.儿童及青少年甲状腺癌分子生物学研究进展[J].中国实用外科杂志, 2022, 42(6):716-720.DOI:10.19538/j.cjps.issn1005-2208.2022.06.24. Yang LY, Guo K, Qian K, et al.Research advances in the molecular biology of thyroid carcinoma in children and adolescents[J].Chin J Pract Surg, 2022, 42(6):716-720.DOI:10.19538/j.cjps.issn1005-2208.2022.06.24.
[8] 杨伟伟, 只璟泰, 郑向前, 等.肥胖儿童和青少年甲状腺乳头状癌患者的临床病理特点分析[J].中华普通外科杂志, 2021, 36(6):432-435.DOI:10.3760/cma.j.cn113855-20200916-00714. Yang WW, Zhi JT, Zheng XQ, et al.Clinicopathological characteristics of papillary thyroid carcinoma in obese children and adolescents[J].Chin J Gen Surg, 2021, 36(6):432-435.DOI:10.3760/cma.j.cn113855-20200916-00714.
[9] 菅雁兵, 王冰, 苗欣, 等.儿童及青少年分化型甲状腺癌的外科治疗及复发影响因素分析[J].解放军医学院学报, 2020, 41(10):967-970, 987.DOI:10.3969/j.issn.2095-5227.2020.10.004. Jian YB, Wang B, Miao X, et al.Surgery for differentiated thyroid cancer in children and adolescents and influencing factors of its recurrence[J].Acad J Chin PLA Med Sch, 2020, 41(10):967-970, 987.DOI:10.3969/j.issn.2095-5227.2020.10.004.
[10] 刘翔, 高明.儿童和青少年甲状腺癌的临床特点和治疗(附59例报告)[J].中国肿瘤临床, 2008, 35(9):494-496.DOI:10.3969/j.issn.1000-8179.2008.09.005. Liu X, Gao M.Clinical features and therapies of thyroid carcinoma in children and adolescents:a report of 59 cases[J].Chin J Clin Oncol, 2008, 35(9):494-496.DOI:10.3969/j.issn.1000-8179.2008.09.005.
[11] 吕静荣, 陈淳, 马衍, 等.儿童分化型甲状腺癌的临床特征及危险因素分析[J].山东大学耳鼻喉眼学报, 2020, 34(3):88-94.DOI:10.6040/j.issn.1673-3770.1.2020.039. Lyu JR, Chen C, Ma Y, et al.Clinical characteristics and risk factors for differentiated thyroid carcinoma in children[J].J Otolaryngol Ophthalmol Shandong Univ, 2020, 34(3):88-94.DOI:10.6040/j.issn.1673-3770.1.2020.039.
[12] Liu YW, Wang SC, Li YZ, et al.Clinical heterogeneity of differentiated thyroid cancer between children less than 10 years of age and those older than 10 years:a retrospective study of 70 cases[J].Eur Thyroid J, 2021, 10(5):364-371.DOI:10.1159/000516830.
[13] Mizukami Y, Michigishi T, Nonomura A, et al.Carcinoma of the thyroid at a young age:a review of 23 patients[J].Histopathology, 1992, 20(1):63-66.DOI:10.1111/j.1365-2559.1992.tb00918.x.
[14] Palmer BA, Zarroug AE, Poley RN, et al.Papillary thyroid carcinoma in children:risk factors and complications of disease recurrence[J].J Pediatr Surg, 2005, 40(8):1284-1288.DOI:10.1016/j.jpedsurg.2005.05.012.
[15] Hay ID, Gonzalez-Losada T, Reinalda MS, et al.Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008[J].World J Surg, 2010, 34(6):1192-1202.DOI:10.1007/s00268-009-0364-0.
[16] Al-Qahtani KH, Tunio MA, Al Asiri M, et al.Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults[J].J Otolaryngol Head Neck Surg, 2015, 44:48.DOI:10.1186/s40463-015-0102-6.
[17] Kluijfhout WP, van Beek DJ, Verrijn Stuart AA, et al.Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2:retrospective cohort analysis[J].Medicine (Baltimore), 2015, 94(29):e1108.DOI:10.1097/MD.0000000000001108.
[18] Raval MV, Browne M, Chin AC, et al.Total thyroidectomy for benign disease in the pediatric patient-feasible and safe[J].J Pediatr Surg, 2009, 44(8):1529-1533.DOI:10.1016/j.jpedsurg.2008.11.032.
[19] Shi RL, Qu N, Yang SW, et al.Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model[J].Onco Targets Ther, 2016, 9:5015-5022.DOI:10.2147/OTT.S107187.
[20] Zimmerman D, Hay ID, Gough IR, et al.Papillary thyroid carcinoma in children and adults:long-term follow-up of 1039 patients conservatively treated at one institution during three decades[J].Surgery, 1988, 104(6):1157-1166.
[21] Collini P, Mattavelli F, Pellegrinelli A, et al.Papillary carcinoma of the thyroid gland of childhood and adolescence:morphologic subtypes, biologic behavior and prognosis:a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period[J].Am J Surg Pathol, 2006, 30(11):1420-1426.DOI:10.1097/01.pas.0000213264.07597.9a.
[22] Francis GL, Waguespack SG, Bauer AJ, et al.Management guidelines for children with thyroid nodules and differentiated thyroid cancer[J].Thyroid, 2015, 25(7):716-759.DOI:10.1089/thy.2014.0460.
[23] Mihailovic J, Nikoletic K, Srbovan D.Recurrent disease in juvenile differentiated thyroid carcinoma:prognostic factors, treatments, and outcomes[J].J Nucl Med, 2014, 55(5):710-717.DOI:10.2967/jnumed.113.130450.
[24] Demidchik YE, Demidchik EP, Reiners C, et al.Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus[J].Ann Surg, 2006, 243(4):525-532.DOI:10.1097/01.sla.0000205977.74806.0b.
[25] Collini P, Massimino M, Leite SF, et al.Papillary thyroid carcinoma of childhood and adolescence:a 30-year experience at the Istituto Nazionale Tumori in Milan[J].Pediatr Blood Cancer, 2006, 46(3):300-306.DOI:10.1002/pbc.20474.
[26] Demidchik YE, Saenko VA, Yamashita S.Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present[J].Arq Bras Endocrinol Metabol, 2007, 51(5):748-762.DOI:10.1590/s0004-27302007000500012.
[27] Wang CY, Chen XH, Wei XY, et al.Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer[J].Asian J Surg, 2017, 40(1):55-60.DOI:10.1016/j.asjsur.2016.09.001.
[28] 焦赞, 付利军, 李利文, 等.14岁以下儿童分化型甲状腺癌预后因素分析[J].中华内分泌外科杂志, 2019, 13(5):419-422.DOI:10.3760/cma.j.issn.1674-6090.2019.05.014. Jiao Z, Fu LJ, Li LW, et al.Prognostic factors of differentiated thyroid carcinoma in children aged under 14 years[J].Chin J Endocr Surg, 2019, 13(5):419-422.DOI:10.3760/cma.j.issn.1674-6090.2019.05.014.
[29] 靳士强, 孟玉梅.儿童分化型甲状腺癌临床病理特点及预后分析[J].世界最新医学信息文摘(电子版), 2013, 13(8):150-151.DOI:10.3969/j.issn.1671-3141.2013.08.104. Jin SQ, Meng YM.Clinicopathological characteristics and prognosis of differentiated thyroid cancer in children[J].World Latest Med Inf, 2013, 13(8):150-151.DOI:10.3969/j.issn.1671-3141.2013.08.104.
[30] Welch Dinauer CA, Tuttle RM, Robie DK, et al.Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults[J].Clin Endocrinol (Oxf), 1998, 49(5):619-628.DOI:10.1046/j.1365-2265.1998.00584.x.
[31] 眭慧敏, 刘杰蕊, 王瞳, 等.儿童及青少年分化型甲状腺癌远处转移的临床病理学危险因素分析[J].中国癌症杂志, 2019, 29(6):423-428.DOI:10.19401/j.cnki.1007-3639.2019.06.004. Sui HM, Liu JR, Wang T, et al.Clinicopathological risk factors for distant metastasis of differentiated thyroid carcinoma in children and adolescents[J].China Oncol, 2019, 29(6):423-428.DOI:10.19401/j.cnki.1007-3639.2019.06.004.
[32] 王兴, 张烨, 赵明, 等.18岁及以下甲状腺乳头状癌患者治疗后远处转移的预测分析[J].中华耳鼻咽喉头颈外科杂志, 2020, 55(7):664-670.DOI:10.3760/cma.j.cn115330-20200115-00025. Wang X, Zhang Y, Zhao M, et al.Predictive analysis of distant metastasis after primary treatment of papillary thyroid cancer in patients aged under 18 years[J].Chin J Otorhinolaryngol Head Neck Surg, 2020, 55(7):664-670.DOI:10.3760/cma.j.cn115330-20200115-00025.
[33] Mao XC, Yu WQ, Shang JB, et al.Clinical characteristics and treatment of thyroid cancer in children and adolescents:a retrospective analysis of 83 patients[J].J Zhejiang Univ Sci B, 2017, 18(5):430-436.DOI:10.1631/jzus.B1600308.
[34] Frankenthaler RA, Sellin RV, Cangir A, et al.Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients[J].Am J Surg, 1990, 160(4):341-343.DOI:10.1016/s0002-9610(05)80538-0.
[35] Pazaitou-Panayiotou K, Iliadou PK, Mandanas S, et al.Papillary thyroid carcinomas in patients under 21 years of age:clinical and histologic characteristics of tumors ≤ 10 mm[J].J Pediatr, 2015, 166(2):451-456.e2.DOI:10.1016/j.jpeds.2014.10.023.
[36] Spinelli C, Tognetti F, Strambi S, et al.Cervical lymph node metastases of papillary thyroid carcinoma, in the central and lateral compartments, in children and adolescents:predictive factors[J].World J Surg, 2018, 42(8):2444-2453.DOI:10.1007/s00268-018-4487-z.
[37] 裴桂英, 姜赤秋.不同评分系统预测危重新生儿死亡放弃风险的准确度及临床价值[J].武汉大学学报(医学版), 2020, 41(3):476-480.DOI:10.14188/j.1671-8852.2019.0848. Pei GY, Jiang CQ.Clinical accuracy and application value of different scoring systems in the prediction of critical neonatal mortality risks[J].Med J Wuhan Univ, 2020, 41(3):476-480.DOI:10.14188/j.1671-8852.2019.0848.
[38] Klein Hesselink MS, Nies M, Bocca G, et al.Pediatric differentiated thyroid carcinoma in the Netherlands:a nationwide follow-up study[J].J Clin Endocrinol Metab, 2016, 101(5):2031-2039.DOI:10.1210/jc.2015-3290.
[39] 吴晓娟, 易斌, 王小林, 等.甲状舌管囊肿合并甲状腺乳头状癌的诊断与治疗[J].临床小儿外科杂志, 2020, 19(5):451-454.DOI:10.3969/j.issn.1671-6353.2020.05.015. Wu XJ, Yi B, Wang XL, et al.Diagnosis and treatment strategies for thyroglossal duct cyst plus papillary thyroid carcinoma[J].J Clin Ped Sur, 2020, 19(5):451-454.DOI:10.3969/j.issn.1671-6353.2020.05.015.
[40] Astl J, Chovanec M, Luke? P, et al.Thyroid carcinoma surgery in children and adolescents-15 years experience surgery of pediatric thyroid carcinoma[J].Int J Pediatr Otorhinolaryngol, 2014, 78(7):990-994.DOI:10.1016/j.ijporl.2014.03.005.
[41] 宗雨晴.儿童分化型甲状腺癌的治疗进展[J].临床小儿外科杂志, 2018, 17(7):552-557.DOI:10.3969/j.issn.1671-6353.2018.07.017. Zong YQ.Recent advances in the treatment of differentiated thyroid cancer in children[J].J Clin Ped Sur, 2018, 17(7):552-557.DOI:10.3969/j.issn.1671-6353.2018.07.017.
[42] 中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组, 中国抗癌协会头颈肿瘤专业委员会, 等.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志, 2012, 28(10):779-797.DOI:10.3760/cma.j.issn.1000-6699.2012.10.002. Endocrinology Branch of Chinese Medical Association, Endocrinology Group, Branch of Surgery, Chinese Medical Association, Head and Neck Cancer Professional Committee of Chinese Anti-Cancer Association, et al:Guidelines for Diagnosing and Treating Thyroid Nodules and Differentiated Thyroid Cancer[J].Chin J Endocrinol Metab, 2012, 28(10):779-797.DOI:10.3760/cma.j.issn.1000-6699.2012.10.002.
[43] Leboulleux S, Hartl D, Baudin E, et al.Differentiated thyroid cancer in childhood[J].Bull Cancer, 2012, 99(11):1093-1099.DOI:10.1684/bdc.2012.1645.
[44] Clement SC, Peeters RP, Ronckers CM, et al.Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma-a systematic review[J].Cancer Treat Rev, 2015, 41(10):925-934.DOI:10.1016/j.ctrv.2015.09.001.

Memo

收稿日期:2022-11-21。
通讯作者:赵舸,Email:13835103128@qq.com

Last Update: 1900-01-01